Conversely, in men with localized prostate cancer with 4.4 years of follow-up, no correlation was found between circulating 25(OH)D levels, vitamin D pathway polymorphisms and prostatic serum antigen (PSA), a well-recognized marker of prostate cancer [63]. Here, KLK3 is linked to prostate carcinoma.